Patients with acute or worsening HF with a Gal-3 level > 17.8 ng/mL, or a Gal-3 level between 9.5 and 17.8 ng/mL and NT pro BNP ≥ 2000 are at high risk of rehospitalization and death. This evidence concerns the gene LGALS3 and hydrops fetalis.